Details for 2016166033

Up to date per 04.04.2026

Actions

Title / Product Name

MODIFIZIERTE RSV-F-PROTEINE UND ANWENDUNGSVERFAHREN DAFÜR

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016166033

EP Publication Number

3067064

E-Number

1269366

Language

PCT Number

Publication Date

14.09.2016 A

13.05.2020 B1

Registration Date

13.05.2020

AT Publication Date

15.06.2020

Application Date

09.12.2009

Registration Number

Priorities

09.12.2008

121126 P

14.04.2009

169077 P

10.07.2009

224787 P

IPC

A61K 39/155 20060101AFI20160804BHEP

Maximum Duration of Protection

09.12.2029

Owner

Novavax, Inc.21 Firstfield Rd, Gaithersburg, MD 20878US

Representative

Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT

Inventor

PUSHKO, PeterNovavax, Inc. 21 Firstfield Rd Gaithersburg, MD 20878US

WU, YingyunNovavax, Inc. 21 Firstfield Rd Gaithersburg, MD 20878US

MASSARE, MichaelNovavax, Inc. 21 Firstfield Rd Gaithersburg, MD 20878US

LIU, YeNovavax, Inc. 21 Firstfield Rd Gaithersburg, MD 20878US

SMITH, GaleNovavax, Inc. 21 Firstfield Rd Gaithersburg, MD 20878US

ZHOU, BinNovavax, Inc. 21 Firstfield Rd Gaithersburg, MD 20878US

Information about Fees